Skip to main navigation Skip to search Skip to main content

Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma

  • Maaike van Dartel
  • , Peter W. A. Cornelissen
  • , Sandra Redeker
  • , Maija Tarkkanen
  • , Sakari Knuutila
  • , Pancras C. W. Hogendoorn
  • , Andries Westerveld
  • , Ingrid Gomes
  • , Johannes Bras
  • , Theo J. M. Hulsebos

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Amplification of region 17p11.2 approximately p12 has been found in 13%-29% of high-grade osteosarcomas, suggesting the presence of an oncogene or oncogenes that may contribute to their development. To determine the location of these putative oncogenes, we established 17p11.2 approximately p12 amplification profiles by semiquantitative PCR, using 15 microsatellite markers and seven candidate genes in 19 high-grade osteosarcomas. Most of the tumors displayed complex amplification profiles, with frequent involvement of marker D17S2041 in 17p12 and TOP3A in 17p11.2 and, in some cases, very high-level amplification of PMP22 and MAPK7 in 17p11.2. Our findings suggest that multiple amplification targets, including PMP22, TOP3A, and MAPK7 or genes close to these candidate oncogenes, may be present in 17p11.2 approximately p12 and thus contribute to osteosarcoma tumorigenesis
Original languageEnglish
Pages (from-to)91-96
JournalCancer genetics and cytogenetics
Volume139
Issue number2
DOIs
Publication statusPublished - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma'. Together they form a unique fingerprint.

Cite this